Your browser doesn't support javascript.
loading
Analysis of the Radiation Therapy Outcomes and Prognostic Factors of Thymoma / 대한방사선종양학회지
The Journal of the Korean Society for Therapeutic Radiology and Oncology ; : 1-8, 2010.
Article in Korean | WPRIM | ID: wpr-46393
ABSTRACT

PURPOSE:

This retrospective study was performed to evaluate the efficacy of radiation therapy (RT) and to investigate the prognostic factors for thymoma when treated with RT. MATERIALS AND

METHODS:

We analyzed 21 patients with thymoma and also received RT from March 2002 to January 2008. The median follow-up time was 37 months (range, 3 to 89 months). The median patient age was 57 years (range, 24 to 77 years) and the gender ratio of males to females was 43. Of the 21 patients, complete resections (trans-sternal thymectomy) and R2 resections were performed in 14 and 1 patient, respectively. A biopsy was performed in 6 patients (28.7%). The WHO cell types in the 21 patients were as follows 1 patient (4.8%) had type A, 10 patients (47.6%) had type B1-3, and 10 patients (47.6%) had type C. Based on Masaoka staging, 10 patients (47.6%) were stage II, 7 patients (33.3%) were stage III, and 4 patients (19.1%) were stage IVa. Three-dimensional RT was adminstered to the tumor volume (planned target volume), including the anterior mediastinum and the residual disease. The total RT dose ranged from 52.0 to 70.2 Gy (median dose, 54 Gy). Consistent with the WHO criteria, the response rate was only analyzed for the 6 patients who received a biopsy only. The prognostic factors analyzed for an estimate of survival included age, gender, tumor size, tumor pathology, Masaoka stage, the possibility of treatment by performing surgery, the presence of myasthenia gravis, and RT dose.

RESULTS:

The 3-year overall survival rate (OS) and the progression free survival rate (PFS) were 80.7% and 78.2%, respectively. Among the 10 patients with WHO cell type C, 3 of 4 patients (75%) who underwent a complete resection and 3 of 6 patients (50%) who underwent a biopsy survived. Distant metastasis developed in 4 patients (19.1%). The overall response rate in the 6 patients who received biopsy only were as follows partial remission in 4 patients (66.7%), stable disease in 1 patient (16.6%), and progressive disease in 1 patient (16.6%). Acute RTOG radiation pneumonitis occurred in 1 patient (4.8%), grade 2 occurred in 2 patients (9.5%), grade 3 occurred in 1 patient (4.8%), and grade 4 occurred in 1 patient (4.8%). A univariate analysis revealed that the significant prognostic factors for OS were age (> or =60, 58.3%; <60, 100%; p=0.0194), pathology (WHO cell type A-B3, 100%; C, 58.3%; p=0.0194) and, whether the patient underwent surgery (yes, 93.3%; no, 50%; p=0.0096).

CONCLUSION:

For the 15 patients who received surgery, there was no local failure within the radiation field. In patients with WHO cell type C, surgical procedures could have resulted in a more favorable outcome than biopsy alone. We report here our clinical experience in 21 patients with thymoma who were treated by radiation therapy.
Subject(s)

Full text: Available Index: WPRIM (Western Pacific) Main subject: Thymectomy / Thymoma / Biopsy / Survival Rate / Retrospective Studies / Follow-Up Studies / Radiation Pneumonitis / Disease-Free Survival / Tumor Burden / Mediastinum Type of study: Observational study / Prognostic study Limits: Female / Humans / Male Language: Korean Journal: The Journal of the Korean Society for Therapeutic Radiology and Oncology Year: 2010 Type: Article

Similar

MEDLINE

...
LILACS

LIS

Full text: Available Index: WPRIM (Western Pacific) Main subject: Thymectomy / Thymoma / Biopsy / Survival Rate / Retrospective Studies / Follow-Up Studies / Radiation Pneumonitis / Disease-Free Survival / Tumor Burden / Mediastinum Type of study: Observational study / Prognostic study Limits: Female / Humans / Male Language: Korean Journal: The Journal of the Korean Society for Therapeutic Radiology and Oncology Year: 2010 Type: Article